Connection

Therese Killeen to Humans

Back to Details
This is a "connection" page, showing publications Therese Killeen has written about Humans.
Therese Killeen
Connection Strength
0.615
Humans
  1. Predictors of Treatment Completion among Women Receiving Integrated Treatment for Comorbid Posttraumatic Stress and Substance Use Disorders. Subst Use Misuse. 2023; 58(4):500-511.
    View in: PubMed
    Score: 0.033
  2. Women with PTSD and Substance Use Disorders in a Research Treatment Study: A Comparison of those with and without the Dissociative Subtype of PTSD. J Trauma Dissociation. 2023 Mar-Apr; 24(2):229-240.
    View in: PubMed
    Score: 0.032
  3. Gender and racial/ethnic differences in physiologic responses in the Stimulant Reduction Intervention using Dosed Exercise Study. Addict Behav. 2020 11; 110:106546.
    View in: PubMed
    Score: 0.028
  4. Exploring the relationship between eating disorder symptoms and substance use severity in women with comorbid PTSD and substance use disorders. Am J Drug Alcohol Abuse. 2015; 41(6):547-52.
    View in: PubMed
    Score: 0.020
  5. Implementation of integrated therapies for comorbid post-traumatic stress disorder and substance use disorders in community substance abuse treatment programs. Drug Alcohol Rev. 2015 May; 34(3):234-41.
    View in: PubMed
    Score: 0.019
  6. Menopause negatively impacts sexual lives of middle-aged Iranian women: a cross-sectional study. J Sex Marital Ther. 2014; 40(6):552-60.
    View in: PubMed
    Score: 0.017
  7. Substance use disorders and anxiety: a treatment challenge for social workers. Soc Work Public Health. 2013; 28(3-4):407-23.
    View in: PubMed
    Score: 0.016
  8. Contingency management in community programs treating adolescent substance abuse: a feasibility study. J Child Adolesc Psychiatr Nurs. 2012 Feb; 25(1):33-41.
    View in: PubMed
    Score: 0.015
  9. Assessment and treatment of co-occurring eating disorders in privately funded addiction treatment programs. Am J Addict. 2011 May-Jun; 20(3):205-11.
    View in: PubMed
    Score: 0.014
  10. The role of alcohol misuse in PTSD outcomes for women in community treatment: a secondary analysis of NIDA's Women and Trauma Study. Drug Alcohol Depend. 2010 Sep 01; 111(1-2):114-9.
    View in: PubMed
    Score: 0.014
  11. Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatment. J Subst Abuse Treat. 2008 Oct; 35(3):304-11.
    View in: PubMed
    Score: 0.012
  12. Effectiveness of motivational incentives in stimulant abusing outpatients with different treatment histories. Am J Drug Alcohol Abuse. 2007; 33(1):129-37.
    View in: PubMed
    Score: 0.011
  13. Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res. 2004 Nov; 28(11):1710-7.
    View in: PubMed
    Score: 0.009
  14. Comparison of self-report versus agency records of service utilization in a community sample of individuals with alcohol use disorders. Drug Alcohol Depend. 2004 Feb 07; 73(2):141-7.
    View in: PubMed
    Score: 0.009
  15. Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics. Drug Alcohol Depend. 2023 03 01; 244:109769.
    View in: PubMed
    Score: 0.008
  16. COPE and oxytocin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in U.S. military veterans. Contemp Clin Trials. 2023 03; 126:107084.
    View in: PubMed
    Score: 0.008
  17. Project Harmony: A Meta-Analysis With Individual Patient Data on Behavioral and Pharmacologic Trials for Comorbid Posttraumatic Stress and Alcohol or Other Drug Use Disorders. Am J Psychiatry. 2023 02 01; 180(2):155-166.
    View in: PubMed
    Score: 0.008
  18. The effect of auricular acupuncture on psychophysiological measures of cocaine craving. Issues Ment Health Nurs. 2002 Jul-Aug; 23(5):445-59.
    View in: PubMed
    Score: 0.008
  19. Measurement Error-Corrected Estimation of Clinically Significant Change Trajectories for Interventions Targeting Comorbid PTSD and Substance Use Disorders in OEF/OIF Veterans. Behav Ther. 2022 09; 53(5):1009-1023.
    View in: PubMed
    Score: 0.008
  20. Estimating posttraumatic stress disorder severity in the presence of differential item functioning across populations, comorbidities, and interview measures: Introduction to Project Harmony. J Trauma Stress. 2022 06; 35(3):926-940.
    View in: PubMed
    Score: 0.008
  21. What's in a name? A data-driven method to identify optimal psychotherapy classifications to advance treatment research on co-occurring PTSD and substance use disorders. Eur J Psychotraumatol. 2022; 13(1):2001191.
    View in: PubMed
    Score: 0.008
  22. Temporal dynamics of symptom change among veterans receiving an integrated treatment for posttraumatic stress disorder and substance use disorders. J Trauma Stress. 2022 04; 35(2):546-558.
    View in: PubMed
    Score: 0.008
  23. Evaluating treatments for posttraumatic stress disorder, alcohol and other drug use disorders using meta-analysis of individual patient data: Design and methodology of a virtual clinical trial. Contemp Clin Trials. 2021 08; 107:106479.
    View in: PubMed
    Score: 0.007
  24. Graded response item response theory in scaling suicidal thoughts and behaviors among trauma-exposed women with substance use disorders. Psychol Addict Behav. 2022 Jun; 36(4):397-409.
    View in: PubMed
    Score: 0.007
  25. Efficacy of mindfulness-based relapse prevention in veterans with substance use disorders: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2021 06; 105:106393.
    View in: PubMed
    Score: 0.007
  26. Putting the Patient Back in Clinical Significance: Moderated Nonlinear Factor Analysis for Estimating Clinically Significant Change in Treatment for Posttraumatic Stress Disorder. J Trauma Stress. 2021 04; 34(2):454-466.
    View in: PubMed
    Score: 0.007
  27. Ethnoracial differences in treatment-seeking veterans with substance use disorders and co-occurring PTSD: Presenting characteristics and response to integrated exposure-based treatment. J Ethn Subst Abuse. 2022 Jul-Sep; 21(3):1141-1164.
    View in: PubMed
    Score: 0.007
  28. Measurement nonequivalence of the Clinician-Administered PTSD Scale by race/ethnicity: Implications for quantifying posttraumatic stress disorder severity. Psychol Assess. 2020 Nov; 32(11):1015-1027.
    View in: PubMed
    Score: 0.007
  29. Parental stress and child behavioral outcomes following substance abuse residential treatment. Follow-up at 6 and 12 months. J Subst Abuse Treat. 2000 Jul; 19(1):23-9.
    View in: PubMed
    Score: 0.007
  30. Crossover between diagnostic and empirical categorizations of full and subthreshold PTSD. J Affect Disord. 2020 09 01; 274:832-840.
    View in: PubMed
    Score: 0.007
  31. The "Women and Trauma" study and its national impact on advancing trauma specific approaches in community substance use treatment and research. J Subst Abuse Treat. 2020 03; 112S:12-17.
    View in: PubMed
    Score: 0.007
  32. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961.
    View in: PubMed
    Score: 0.007
  33. Skin conductance hypo-responding in recently abstinent cocaine dependent inpatients. Am J Addict. 2000; 9(2):154-62.
    View in: PubMed
    Score: 0.007
  34. Estimation of equable scale scores and treatment outcomes from patient- and clinician-reported PTSD measures using item response theory calibration. Psychol Assess. 2020 Apr; 32(4):321-335.
    View in: PubMed
    Score: 0.007
  35. Assessing the needs of front-line providers in addressing the opioid crisis in South Carolina. J Subst Abuse Treat. 2020 01; 108:4-8.
    View in: PubMed
    Score: 0.006
  36. Does trauma-focused exposure therapy exacerbate symptoms among patients with comorbid PTSD and substance use disorders? Behav Cogn Psychother. 2020 Jan; 48(1):38-53.
    View in: PubMed
    Score: 0.006
  37. Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes? Drug Alcohol Depend. 2019 06 01; 199:70-75.
    View in: PubMed
    Score: 0.006
  38. Heterogeneity of treatment dropout: PTSD, depression, and alcohol use disorder reductions in PTSD and AUD/SUD treatment noncompleters. Clin Psychol Psychother. 2019 Mar; 26(2):218-226.
    View in: PubMed
    Score: 0.006
  39. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans. Addict Behav. 2019 03; 90:369-377.
    View in: PubMed
    Score: 0.006
  40. Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure. Addict Behav. 2019 03; 90:35-39.
    View in: PubMed
    Score: 0.006
  41. Prevalence of obesity for opioid- and stimulant-dependent participants in substance use treatment clinical trials. Drug Alcohol Depend. 2018 09 01; 190:255-262.
    View in: PubMed
    Score: 0.006
  42. Rationale, design, and implementation of a clinical trial of a mindfulness-based relapse prevention protocol for the treatment of women with comorbid post traumatic stress disorder and substance use disorder. Contemp Clin Trials. 2017 10; 61:108-114.
    View in: PubMed
    Score: 0.006
  43. The Role of Relationship Adjustment in an Integrated Individual Treatment for PTSD and Substance Use Disorders Among Veterans: An Exploratory Study. J Dual Diagn. 2017 Jul-Sep; 13(3):213-218.
    View in: PubMed
    Score: 0.006
  44. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial. Psychother Psychosom. 2017; 86(3):150-161.
    View in: PubMed
    Score: 0.006
  45. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout. Addict Behav. 2017 10; 73:30-35.
    View in: PubMed
    Score: 0.006
  46. Integrated Treatment of PTSD and Substance Use Disorders: Examination of Imaginal Exposure Length. J Trauma Stress. 2017 04; 30(2):166-172.
    View in: PubMed
    Score: 0.005
  47. Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE): A Pilot Study in Alcohol-dependent Women. J Addict Med. 2017 Mar/Apr; 11(2):119-125.
    View in: PubMed
    Score: 0.005
  48. Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity. J Consult Clin Psychol. 2017 Mar; 85(3):274-281.
    View in: PubMed
    Score: 0.005
  49. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict. 2017 Mar; 26(2):136-144.
    View in: PubMed
    Score: 0.005
  50. Concurrent treatment of PTSD and alcohol use disorder via telehealth in a female Iraq veteran. Am J Addict. 2017 Mar; 26(2):112-114.
    View in: PubMed
    Score: 0.005
  51. Concurrent Treatment of Substance Use and PTSD. Curr Psychiatry Rep. 2016 08; 18(8):70.
    View in: PubMed
    Score: 0.005
  52. Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders. J Subst Abuse Treat. 2016 09; 68:74-82.
    View in: PubMed
    Score: 0.005
  53. Design and methods for the Better Resiliency Among Veterans and non-Veterans with Omega-3's (BRAVO) study: A double blind, placebo-controlled trial of omega-3 fatty acid supplementation among adult individuals at risk of suicide. Contemp Clin Trials. 2016 Mar; 47:325-33.
    View in: PubMed
    Score: 0.005
  54. Vilazodone for cannabis dependence: A randomized, controlled pilot trial. Am J Addict. 2016 Jan; 25(1):69-75.
    View in: PubMed
    Score: 0.005
  55. Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study. Contemp Clin Trials. 2016 Jan; 46:30-38.
    View in: PubMed
    Score: 0.005
  56. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug Alcohol Depend. 2015 Nov 01; 156:29-37.
    View in: PubMed
    Score: 0.005
  57. To reduce or abstain? Substance use goals in the treatment of veterans with substance use disorders and comorbid PTSD. Am J Addict. 2015 Oct; 24(7):578-81.
    View in: PubMed
    Score: 0.005
  58. Family composition and symptom severity among Veterans with comorbid PTSD and substance use disorders. Addict Behav. 2015 Nov; 50:117-23.
    View in: PubMed
    Score: 0.005
  59. Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry. Am J Addict. 2015 Jun; 24(4):336-40.
    View in: PubMed
    Score: 0.005
  60. Addiction severity, psychopathology and treatment compliance in cocaine-dependent mothers. J Addict Dis. 1995; 14(1):75-84.
    View in: PubMed
    Score: 0.005
  61. Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study. J Psychiatr Res. 2014 Mar; 50:26-35.
    View in: PubMed
    Score: 0.004
  62. Substance use disorders and PTSD: an exploratory study of treatment preferences among military veterans. Addict Behav. 2014 Feb; 39(2):369-73.
    View in: PubMed
    Score: 0.004
  63. Alcoholism and liver transplantation: ethical and nursing implications. Perspect Psychiatr Care. 1993 Jan-Mar; 29(1):7-12.
    View in: PubMed
    Score: 0.004
  64. Use of an integrated therapy with prolonged exposure to treat PTSD and comorbid alcohol dependence in an Iraq veteran. Am J Psychiatry. 2012 Jul; 169(7):688-91.
    View in: PubMed
    Score: 0.004
  65. Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network. J Subst Abuse Treat. 2013 Jan; 44(1):103-14.
    View in: PubMed
    Score: 0.004
  66. Helping alliance, retention, and treatment outcomes: a secondary analysis from the NIDA Clinical Trials Network Women and Trauma Study. Subst Use Misuse. 2012 May; 47(6):695-707.
    View in: PubMed
    Score: 0.004
  67. Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findings. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):301-12.
    View in: PubMed
    Score: 0.004
  68. Assessing drug use during follow-up: direct comparison of candidate outcome definitions in pooled analyses of addiction treatment studies. Am J Drug Alcohol Abuse. 2011 Sep; 37(5):358-66.
    View in: PubMed
    Score: 0.004
  69. Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders. Drug Alcohol Depend. 2012 Jan 01; 120(1-3):55-64.
    View in: PubMed
    Score: 0.004
  70. A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder. Am J Addict. 2010 Nov-Dec; 19(6):481-9.
    View in: PubMed
    Score: 0.004
  71. Survey of eating disorder symptoms among women in treatment for substance abuse. Am J Addict. 2010 May-Jun; 19(3):245-51.
    View in: PubMed
    Score: 0.003
  72. A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):132-8.
    View in: PubMed
    Score: 0.003
  73. Multisite randomized trial of behavioral interventions for women with co-occurring PTSD and substance use disorders. J Consult Clin Psychol. 2009 Aug; 77(4):607-19.
    View in: PubMed
    Score: 0.003
  74. The impact of trauma-focused group therapy upon HIV sexual risk behaviors in the NIDA Clinical Trials Network "Women and trauma" multi-site study. AIDS Behav. 2010 Apr; 14(2):421-30.
    View in: PubMed
    Score: 0.003
  75. Assessment and treatment of co-occurring eating disorders in publicly funded addiction treatment programs. Psychiatr Serv. 2008 Sep; 59(9):1056-9.
    View in: PubMed
    Score: 0.003
  76. Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder. J Clin Psychiatry. 2008 Apr; 69(4):520-5.
    View in: PubMed
    Score: 0.003
  77. Long-term outcomes following decompressive craniectomy for severe head injury. Acta Neurochir Suppl. 2008; 102:29-31.
    View in: PubMed
    Score: 0.003
  78. Effectiveness of abstinence-based incentives: interaction with intake stimulant test results. J Consult Clin Psychol. 2007 Oct; 75(5):805-11.
    View in: PubMed
    Score: 0.003
  79. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry. 2005 Oct; 62(10):1148-56.
    View in: PubMed
    Score: 0.002
  80. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004; 19(3):190-6.
    View in: PubMed
    Score: 0.002
  81. Comparative profiles of women with PTSD and comorbid cocaine or alcohol dependence. Am J Drug Alcohol Abuse. 2003; 29(1):169-89.
    View in: PubMed
    Score: 0.002
  82. Comorbidity of psychiatric disorders and posttraumatic stress disorder. J Clin Psychiatry. 2000; 61 Suppl 7:22-32.
    View in: PubMed
    Score: 0.002
  83. Victimization and PTSD in individuals with substance use disorders: gender and racial differences. Am J Drug Alcohol Abuse. 1996 Feb; 22(1):75-93.
    View in: PubMed
    Score: 0.001
  84. Depression in alcoholic schizophrenic patients. Am J Psychiatry. 1993 Aug; 150(8):1255-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.